Rare Disease Supporters Suggest Permanent PRV Program, Even If It May Concern FDA

Non-profit biotech founder says permanent pediatric rare disease priority review voucher program will boost incentive, but FDA is concerned about resource drain vouchers cause.

Capitol House

Rare disease advocates want to add more certainty to the pediatric rare disease priority review voucher program, although that may put them at odds with the US FDA.

The pediatric rare disease priority review voucher program has generated hundreds of millions for sponsors, but the program will sunset...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Rare Diseases

More from Pink Sheet